PATENT CLAIM ANALYSIS

Application Number: 15864856
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["514", "015400"]

Abstract:
The present invention derives from the finding that increased levels of Toll like receptor 4 (TLR4) is associated with liver failure and renal dysfunction and/or brain dysfunction and that by decreasing TLR4 levels in vivo, the kidney and brain consequences of liver disease that are precipitated by superimposed infection or inflammation may be reduced. Accordingly, the invention provides TLR4 antagonists for use in a method of treating an individual suffering from liver disease presenting with renal or brain dysfunction.

Claim (Index 15):
The method of  claim 14 , wherein the patient has been diagnosed with organ dysfunction.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 1.46552
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13817374', '14385332', '11123364', '11720268', '13162160']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7180049820554943
- 35 USC 102 Novelty (BERT): 0.5929605824156364
- Combined Prediction Score: 0.7055005420915086
- Mean Citation Score: 293.91368
- Max Citation Score: 586.32117
- Similarity Product: 378.0712526476729

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test